MP Endsley, MA Isbell, L Cui, CE Wheelock, BD Hammock, JR Falck, WB Campbell, and K Nithipatikom, 2007. Effects of exogenous 2-arachidonoylglycerol hydrolysis and 12-lipoxygenase on prostate carcinoma (PC-3) cell invasion. International Journal of Cancer 121(5):984-991.
CE Wheelock, S Goto, BD Hammock, and JW Newman, 2007. Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics 3(2):137-145.
CJ Hillard, W-S V Ho, J Thompson, K M Gauthier, CE Wheelock, H Huang and BD Hammock, 2007. Effects of catabolic inhibitors on vasodilation of rat middle cerebral artery by the endocannabinoid, 2-arachidonylglycerol. British Journal Pharmacology 152(5):691-698.
T Kadowaki, CE Wheelock, T Adachi, T Kudo, S Okamoto, N Tanaka, K Tonomura, G Tsujimoto, H Mamitsuka, S Goto, and M Kanehisa, 2007. Identification of endocrine disruptor biodegradation by integration of structure-activity relationship with pathway analysis. Environ Science and Technology 41:7997-8003.
J Normark, D Nilsson, U Ribacke, G Winter, K Moll, CE Wheelock, J Bayarugaba, F Kironde, TG Egwang, Q Chen, B Andersson, and M Wahlgren, 2007. PfEMP1 motifs predict severity of Plasmodium falciparum malaria. PNAS 104(40):15835-15840.